Munich Re Heads to New York with a Record Quarter — and a Stock Near Its Floor

Munich Re reports Q1 profit surge to €1.714B, but shares slide 19% YoY as disciplined renewal strategy cuts volume. Analysts see upside with buyback plan.

Munich Re’s management team is in New York this week for the Deutsche Bank Global Financial Services Conference, armed with a first-quarter profit that jumped 57% to €1.714 billion. But the narrative they face is a stark one: the reinsurer’s shares slid to a fresh 52-week low of €460.10 earlier this week, a decline of roughly 19% from a year ago. The stock has since recovered marginally to €469.60, trading just 0.49% above its previous cycle floor of €467.30. Since the start of the year, the shares have lost 14–16% of their value depending on the reference point.

The operating numbers tell a more buoyant story. Munich Re’s combined ratio in property-casualty reinsurance improved to 66.8%, while the underwriting result in the same division came in at €1.479 billion. Life-health reinsurance contributed €500 million to group earnings, and the ERGO primary insurance unit added €235 million. The group’s operating profit reached €2.23 billion. Yet the market has chosen to focus on headwinds elsewhere, particularly in pricing.

At the April 2026 renewals, the volume of business written dropped 18.5% to €2.0 billion as Munich Re walked away from contracts that did not meet its return thresholds. Prices fell by a risk-adjusted 3.1%, and the renewal cycle — which covers about 11% of the group’s non-life portfolio — saw deliberate shrinkage in Japan and India. That discipline is central to the company’s strategy of prioritizing profitability over volume, but it has left some investors wondering whether top-line erosion will eventually catch up with earnings.

Analysts remain broadly constructive despite the cut in expectations. Barclays trimmed its price target from €606 to €575 on May 26 but kept an “Overweight” rating, implying roughly 25% upside from current levels. JP Morgan and Jefferies have targets of €590 and €600, respectively, all updated in May. The average analyst target sits well above the market price — an unusually wide gap that suggests either the stock is deeply undervalued or the market sees risks not yet captured in those models.

One factor adding to the technical pressure is the relative strength index, which has climbed to 76.5 — indicating overbought conditions despite the weak price action. That paradox points to persistent selling pressure rather than natural exhaustion of the downtrend. Since hitting a 52-week high of €605.00 last August, the stock has dropped more than 22%.

Management is fighting back with a €2.25 billion share buyback program launched in late April and running until the annual general meeting in April 2027. Together with the €24.00 per share dividend paid for the 2025 financial year, the total capital return plan calls for up to €5.3 billion to be sent back to shareholders. The buyback was already factored into a solvency ratio of 292% at the end of March, well above the 200% target under Solvency II.

The near-term outlook hinges on two big unknowns: the July renewal season and the Atlantic hurricane cycle. Munich Re’s climate modelers expect slightly below-normal hurricane activity in 2026 due to El Niño conditions, though typhoon risk in the western Pacific could be elevated. The company has repeatedly stressed its willingness to walk away from underpriced contracts, a stance that will be tested again in the mid-year renewals. The half-year report on August 7 and the third-quarter update on November 12 will serve as the next major checkpoints for whether the operational momentum can survive the pricing headwinds — and whether the share price can finally find a floor.